WASHINGTON, D.C.–(ENEWSPF)–September 12, 2012. U.S. Senators Dick Durbin (D-IL) and Richard Blumenthal (D-CT) today asked the Food and Drug Administration to respond to their specific concerns regarding the interaction of ingredients in energy drinks and the effect that the caffeine in energy drinks has on children and adolescents. In[Read More…]
Health and Fitness
It’s Time to Get Your Flu Shot
No excuses – you cannot get the flu from a flu shot SPRINGFIELD–(ENEWSPF)–September 12, 2012. Influenza vaccine is starting to arrive at local health departments, pharmacies and health care clinics around the state. The Illinois Department of Public Health, along with the Centers for Disease Control and Prevention (CDC), is[Read More…]
NIH Expands Safe Infant Sleep Outreach Effort
‘Safe to sleep’ seeks to reduce risk of sleep-related infant death Bethesda, Maryland–(ENEWSPF)–September 12, 2012. The U.S. national campaign to reduce the risk of sudden infant death syndrome has entered a new phase and will now encompass all sleep-related, sudden unexpected infant deaths, officials of the National Institutes of Health[Read More…]
Common Application for HIV Patient Assistance Program Expedites Application Process for Lifesaving Drugs
Washington, DC–(ENEWSPF)–September 12, 2012. The Common Patient Assistance Program Application (CPAPA), announced by Health and Human Services (HHS) Secretary Kathleen Sebelius at the International AIDS Conference in July, went into effect today. This single common application allows uninsured individuals living with HIV to use one application to apply for multiple[Read More…]
FDA Approves Production of Imaging Agent That Helps Detect Prostate Cancer
Mayo Clinic is the first facility approved to manufacture Choline C 11 Injection Silver Spring, Maryland–(ENEWSPF)–September 12, 2012. The U.S. Food and Drug Administration today approved the production and use of Choline C 11 Injection, a Positron Emission Tomography (PET) imaging agent used to help detect recurrent prostate cancer. Choline C 11[Read More…]
Planned Parenthood and the National Latina Institute for Reproductive Health to Celebrate Poderosas: Champions of Latina Health in Congress
NEW YORK–(ENEWSPF)–September 11, 2012. Planned Parenthood Federation of America (PPFA) and the National Latina Institute for Reproductive Health (NLIRH) will honor the Latina members of Congress for their tireless support of women’s health and rights on Wednesday, September 12, in Washington, DC. The Congresswomen who will be honored are Rep.[Read More…]
Novartis Challenge Against India’s Pro-Health Patent Law Heads to Indian Supreme Court
Graphic by Will Owen View Infographic NEW DELHI/GENEVA/NEW YORK–(ENEWSPF)–SEPTEMBER 11, 2012—The Swiss pharmaceutical company Novartis heads to the Indian Supreme Court today in New Delhi, in a final bid to undermine a key public health safeguard in Indian patent law specifically designed to prevent drug companies from abusive patenting practices[Read More…]
Pain Drug Can Kill Resistant Tuberculosis
Researchers Find Low Cost Drug Wipes Out Drug Resistant TB, But Worry it May Not Reach Patients in Need NEW YORK–(ENEWSPF)–September 11, 2012 — An off-patent anti-inflammatory drug that costs around two cents for a daily dose in developing countries has been found by researchers at Weill Cornell Medical College[Read More…]
Former NFL Players at Increased Risk of Death from Neurodegenerative Causes, NIOSH Study Finds
Atlanta, GA–(ENEWSPF)–September 10, 2012. A new study published by the National Institute for Occupational Safety and Health (NIOSH) found that National Football League (NFL) players may be at a higher risk of death associated with Alzheimer’s and other impairments of the brain and nervous system than the general U.S. population.[Read More…]
Subsidiary of Diet Plan Marketer Medifast Inc. to Pay $3.7 Million to Settle FTC Charges
Unsupported Weight-Loss Claims Violated Previous Order, Agency Alleges Washingto, DC–(ENEWSPF)–September 10, 2012. A subsidiary of diet plan marketer Medifast Inc. will pay a $3.7 million civil penalty to settle Federal Trade Commission charges that it violated a previous agency order by making unsupported claims about its weight-loss program. Medifast unit[Read More…]





